Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Vienna
Clinical trial register · Austria

Clinical Trials in Vienna, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Austria and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1586 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:18 UTC
1586
Studies in scope
all four open statuses
855
Recruiting now
open to new participants
341
Lead sponsors
across recruiting studies
Top sites
Vienna 1013 Graz 514 Linz 434 Innsbruck 396 Salzburg 292
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Medical University of Vienna144 AstraZeneca44 AbbVie27 Novartis Pharmaceuticals25 Eli Lilly and Company23 Merck Sharp & Dohme LLC22 Bristol-Myers Squibb22 Hoffmann-La Roche21 Janssen Research & Development, LLC20 Sanofi14 University of Vienna13 argenx12 Amgen11 Takeda10 Celgene10 Bayer10 Daiichi Sankyo9 Pfizer9 Boehringer Ingelheim9 Incyte Corporation9 Novo Nordisk A/S8 University Hospital, Basel, Switzerland8 Sigmund Freud PrivatUniversitat7 Exelixis7 Gilead Sciences7 Show all 352
Site location
Vienna1013 Graz514 Linz434 Innsbruck396 Salzburg292 Sankt Pölten115 Wels90 Klagenfurt64 Feldkirch51 Krems35 Wiener Neustadt34 Leoben25 Rankweil25 Braunau am Inn17 Steyr12 Vöcklabruck7 Schwaz7 Mattersburg7 Sankt Veit an der Glan7 Kufstein6 Dornbirn6 Tulln5 Wein5 Mistelbach5 Eisenstadt4 Show all 99
All 99 locations
Target enrolment
to

Trials with a site in Vienna

1013 of 1586 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Austria
Start
Active, closed
argenx
Observational
413
Vienna
2023-11-29
Active, closed
AstraZeneca
Phase 3
1,898
Graz, Innsbruck, Krems, Linz, Vienna
2023-11-21
Recruiting
Amgen
Phase 3
750
Graz, Klagenfurt, Krems, Oberwart, Salzburg, Vienna, Wels
2023-11-16
Recruiting
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
NCT05658640Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
DrugsTrametinib·Cytarabine·Dexamethasone·Cyclophosphamide
Princess Maxima Center for Pediatric Oncology
Phase 1/2
26
Vienna
2023-11-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Sankt Pölten, Graz, Leoben, Innsbruck, Linz, Vienna, Wels
2023-11-14
Active, closed
BeOne Medicines
Phase 3
652
Innsbruck, Salzburg, Vienna
2023-11-11
Active, closed
AstraZeneca
Phase 3
314
Graz, Innsbruck, Vienna
2023-11-08
Active, closed
AstraZeneca
Phase 3
1,835
Feldkirch, Vienna
2023-11-07
Recruiting
Trifecta-Lung cfDNA-MMDx Study
NCT05837663Lung Transplantation
University of Alberta
Observational
600
Vienna
2023-11-01
Recruiting
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
NCT05786131Non-ST-elevation Myocardial Infarction, Multivessel Coronary Artery Disease
Leipzig Heart Science gGmbH
Not applicable
3,390
Graz, Innsbruck, Vienna
2023-10-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Vienna, Innsbruck, Salzburg
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Salzburg, Linz, Vienna
2023-10-25
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Graz, Innsbruck, Klagenfurt, Leoben, Linz, Rankweil, Salzburg, Vienna
2023-10-24
Recruiting
Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma
NCT07034053Advanced Urothelial Carcinoma, Metastatic Urothelial Cancer
DrugClofarabine
Ekaterina Laukhtina
Phase 1/2
50
Vienna
2023-10-24
Recruiting
Confocal Laser Endomicroscopy VERification
NCT06079970Lung Cancer, Lung Neoplasm Malignant, Carcinoma, Non-Small-Cell Lung, Neoplasm of Lung
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Not applicable
208
Vienna
2023-10-18
Active, closed
Celgene
Phase 3
79
Salzburg, Vienna
2023-10-16
Recruiting
Sanofi
Phase 3
180
Vienna
2023-10-10
Active, closed
AstraZeneca
Phase 3
5,511
Graz, Innsbruck, Linz, Salzburg, Sankt Veit an der Glan, Steyr, Vienna, Wels
2023-10-05
Recruiting
Medical University of Vienna
Not applicable
100
Vienna
2023-10-01
Recruiting
Medical University of Vienna
Not applicable
86
Vienna
2023-10-01
Active, closed
AstraZeneca
Phase 1/2
166
Graz, Vienna
2023-09-29
Active, closed
PharmaMar
Phase 3
469
Graz, Innsbruck, Linz, Vienna
2023-09-21
Recruiting
Medical University of Vienna
Not applicable
100
Vienna
2023-09-19
Recruiting
Outcome of Two Surgical Methods for IOLImplantation in Eyes With Pseudoexfoliation Syndrome
NCT06053554Age Related Cataracts, Pseudoexfoliation Syndrome
Medical University of Vienna
Not applicable
120
Vienna
2023-09-18
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Salzburg, Linz, Vienna
2023-09-14
Active, closed
Bristol-Myers Squibb
Phase 3
774
Graz, Vienna
2023-09-11
Recruiting
Biotest
Phase 3
590
Klagenfurt, Vienna
2023-09-09
Recruiting
Gilead Sciences
Phase 3
402
Hall in Tirol, Vienna, Wels
2023-09-07
Recruiting
The ReTAVI Prospective Observational Registry
NCT05601453Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction
Institut für Pharmakologie und Präventive Medizin
Observational
250
Graz, Linz, Sankt Pölten, Vienna
2023-09-05
Active, closed
Effects of a Home-Based Exercise Intervention in Subjects with Long COVID
NCT06073002Long COVID-19, Post-COVID-19 Syndrome
University of Vienna
Not applicable
20
Vienna
2023-09-04
Recruiting
The Effect of Desflurane Versus Sevoflurane Versus Propofol on Postoperative Delirium
NCT05990790Postoperative Delirium, Major Noncardiac Surgery, Postoperative Cognitive Dysfunction
DrugsDesflurane·Sevoflurane·Propofol
Medical University of Vienna
Phase 4
1,332
Innsbruck, Vienna
2023-09-03
Active, closed
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731Ventricular Arrhythmia, Tachycardia
Medtronic
Observational
1,000
Graz, Innsbruck, Linz, Vienna
2023-09-01
Active, closed
Medical University of Vienna
Observational
30
Vienna
2023-08-15
Recruiting
Novartis Pharmaceuticals
Phase 4
700
Linz, Vienna
2023-08-14
Active, closed
Takeda
Phase 3
200
Vienna
2023-08-08
Recruiting
Xanthohumol and Viral Infections (XL)
NCT06286657Infection Viral
University of Vienna
Not applicable
100
Vienna
2023-08-01
Active, closed
MED-EL Elektromedizinische Geräte GmbH
Not applicable
20
Innsbruck, Vienna
2023-07-27
Recruiting
Kartos Therapeutics, Inc.
Phase 2/3
268
Graz, Innsbruck, Vienna
2023-07-17
Recruiting
University Hospital, Basel, Switzerland
Not applicable
280
Sankt Pölten, Vienna
2023-07-14
Recruiting
Medical University of Vienna
Not applicable
285
Vienna
2023-07-14
Recruiting
Exploring Radiotherapy of Temporomandibular Joint Arthritis
NCT05716737Arthritis of Temporomandibular Joint
Medical University of Vienna
Not applicable
10
Vienna
2023-07-07
Active, closed
Prim. Prof. Dr. Oliver Findl, MBA
Not applicable
24
Vienna
2023-07-06
Active, closed
Hansa Biopharma AB
Phase 3
150
Vienna
2023-07-03
Active, closed
Medical University of Vienna
Phase 2
20
Vienna
2023-07-01
Active, closed
iOMEDICO AG
Observational
75
Vienna
2023-06-28
Recruiting
Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )
NCT05919940ICU Acquired Weakness, Muscle Atrophy, Energy Malnutrition Protein, Quality of Life
Technical University of Munich
Not applicable
40
Vienna
2023-06-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Linz, Sankt Pölten, Vienna
2023-06-22
Active, closed
Population Health Research Institute
Not applicable
5,100
Vienna
2023-06-22
Recruiting
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
NCT05427370Coronary Artery Disease, Heart Failure Systolic
Sunnybrook Health Sciences Centre
Not applicable
754
Vienna
2023-06-22
Active, closed
AbbVie
Phase 3
1,328
Vienna, Graz, Linz
2023-06-21
Active, closed
Cutting Edge SAS
Not applicable
251
Vienna
2023-06-21
Recruiting
CSL Behring
Observational
500
Vienna
2023-06-15
Recruiting
Servier Affaires Médicales
Phase 3
245
Vienna, Wels
2023-06-14
Active, closed
Alfasigma S.p.A.
Observational
509
Graz, Klagenfurt, Sankt Veit an der Glan, Vienna
2023-06-12
Active, closed
10°C vs 4°C Lung Preservation RCT
NCT05898776Lung Transplant, Organ Preservation
University Health Network, Toronto
Not applicable
317
Vienna
2023-06-09
Active, closed
AbbVie
Observational
1,019
Sankt Pölten, Vienna, Graz, Innsbruck, Wels
2023-06-09
Not yet open
Single-Dose Intravesical Chemotherapy After Diagnostic URS
NCT05810623Upper Urinary Tract Urothelial Carcinoma, Bladder Cancer
David D'Andrea
Phase 3
394
Vienna
2023-06-01
Recruiting
Pfizer
Phase 2
100
Vienna
2023-05-17
Active, closed
Jena University Hospital
Phase 3
250
Linz, Vienna
2023-05-16
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Innsbruck, Salzburg, Vienna
2023-05-09
Active, closed
Gilead Sciences
Phase 3
654
Innsbruck, Salzburg, Vienna, Wels
2023-05-08
Active, closed
Servier Affaires Médicales
Phase 3
299
Graz, Linz, Salzburg, Vienna
2023-05-03
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Innsbruck, Vienna
2023-04-25
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Graz, Innsbruck, Linz, Vienna
2023-04-17
Active, closed
TrEatment Approach in the Multimodal Era Registry
NCT05629052Chronic Thromboembolic Pulmonary Hypertension, CTEPH
International CTEPH Association
Observational
1,000
Vienna
2023-04-12
Active, closed
Bayer
Phase 3
985
Vienna, Salzburg, Innsbruck, Linz
2023-04-03
Active, closed
Relevance of Reversible Causes During OHCA (Rebecca Study)
NCT05784480Out-Of-Hospital Cardiac Arrest, Cardiopulmonary Arrest
Medical University of Vienna
Not applicable
100
Vienna
2023-04-01
Recruiting
AstraZeneca
Phase 3
4,300
Graz, Kufstein, Ried, Sankt Veit an der Glan, Vienna, Wein, Wels
2023-03-31
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Salzburg, Vienna
2023-03-29
Recruiting
The DefiPace Study
NCT04804748Post-operative Atrial Fibrillation POAF
Institut für Pharmakologie und Präventive Medizin
Observational
450
Vienna
2023-03-28
Active, closed
Boston Scientific Corporation
Observational
1,173
Vienna
2023-03-24
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
1,650
Innsbruck, Vienna
2023-03-21
Active, closed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
125
Innsbruck, Linz, Salzburg, Sankt Pölten, Vienna
2023-03-20
Recruiting
Vega Therapeutics, Inc
Phase 1/2
116
Vienna
2023-03-16
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Braunau am Inn, Graz, Linz, Vienna
2023-03-09
Active, closed
Insmed Incorporated
Phase 2/3
91
Linz, Vienna
2023-03-07
Recruiting
Takeda
Phase 3
160
Graz, Innsbruck, Klagenfurt, Vienna
2023-03-06
Active, closed
Bristol-Myers Squibb
Phase 3
579
Graz, Salzburg, Sankt Pölten, Vienna
2023-03-06
Recruiting
Medical University of Vienna
Observational
50
Vienna
2023-03-03
Recruiting
Medical University of Vienna
Observational
1,500
Vienna
2023-03-01
Recruiting
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
NCT05797519Tricuspid Regurgitation, Tricuspid Valve Disease, Tricuspid Valvular Disorders
VDyne, Inc.
Not applicable
120
Linz, Vienna
2023-03-01
Active, closed
AstraZeneca
Observational
551
Innsbruck, Linz, Vienna
2023-02-27
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
DrugsTovorafenib·Carboplatin
Day One Biopharmaceuticals, Inc.
Phase 3
418
Innsbruck, Vienna
2023-02-27
Active, closed
VIATORR Device Registry
NCT05661331Chronic Liver Disease
W.L.Gore & Associates
Observational
196
Vienna
2023-02-21
Recruiting
Medical University of Vienna
Observational
10
Vienna
2023-02-16
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Innsbruck, Linz, Salzburg, Vienna
2023-02-14
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Innsbruck, Vienna
2023-02-13
Active, closed
Kite, A Gilead Company
Phase 3
300
Innsbruck, Salzburg, Sankt Pölten, Vienna
2023-02-10
Active, closed
Genmab
Phase 3
900
Sankt Pölten, Salzburg, Vienna
2023-02-08
Recruiting
Medical University of Vienna
Observational
50
Vienna
2023-02-06
Active, closed
Novartis Pharmaceuticals
Phase 3
152
Vienna
2023-02-02
Active, closed
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
NCT05478304Ischemic Stroke, Systemic Embolism
AtriCure, Inc.
Not applicable
6,573
Graz, Vienna
2023-01-25
Recruiting
Jazz Pharmaceuticals
Phase 3
510
Vienna
2023-01-23
Recruiting
Retrospective Register for Uveal Melanoma
NCT05733728Uveal Melanoma
Medical University of Vienna
Observational
1,400
Vienna
2023-01-23
Recruiting
Coagulation in Cirrhosis
NCT05667805Liver Cirrhosis
DrugProthrombin complex
Medical University of Vienna
Phase 4
400
Vienna
2023-01-19
Active, closed
argenx
Phase 2
51
Vienna
2023-01-18
Active, closed
Daiichi Sankyo
Phase 3
1,233
Feldkirch, Klagenfurt, Vienna
2023-01-11
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
247
Vienna
2023-01-11
Active, closed
Bristol-Myers Squibb
Phase 3
606
Vienna, Linz
2023-01-10
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
NCT05701917Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome
Inari Medical
Not applicable
300
Vienna
2023-01-06
Recruiting
Mycobacteria Registry Study: Prospective Observational Study in Austria
NCT06522347Non-Tuberculous Mycobacterial Pneumonia, Tuberculosis
Ludwig Boltzmann Institute for Lung Health
Observational
1,000
Vienna
2023-01-01
Recruiting
ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank
NCT06162546Focal Segmental Glomerulosclerosis, Proteinuria, Nephrotic Syndrome, Nephrotic Syndrome Steroid-Resistant
Christoph Aufricht
Observational
100
Vienna
2023-01-01
Active, closed
Medical University of Vienna
Phase 4
66
Vienna
2023-01-01
By invitation
European TIF2.0 Registry
NCT07395219Gastro -Oesophagal Reflux, Laryngo-pharyngeal Reflux
Cleveland Clinic London
Observational
500
Vienna
2023-01-01
Active, closed
AstraZeneca
Phase 3
1,350
Graz, Rankweil, Vienna
2022-12-29
By invitation
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
NCT05396105Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II
DrugDeucrictibant
Pharvaris Netherlands B.V.
Phase 2/3
150
Graz, Vienna
2022-12-28
Recruiting
European Myeloma Network (EMN) Sample Project
NCT06237803Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma
European Myeloma Network B.V.
Observational
6,000
Linz, Vienna
2022-12-21
Recruiting
Immunocore Ltd
Phase 3
540
Graz, Linz, Salzburg, Vienna
2022-12-19
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Graz, Innsbruck, Salzburg, Vienna
2022-12-15
Active, closed
Amgen
Phase 3
7,297
Feldkirch, Graz, Klagenfurt, Linz, Salzburg, Sankt Pölten, Vienna
2022-12-14
Active, closed
Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
NCT05619653COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction
DrugsLosartan·Prednisolone
Valentina Puentmann
Phase 3
279
Vienna
2022-12-12
Recruiting
Pfizer
Phase 3
100
Vienna
2022-12-09
Active, closed
Celcuity Inc
Phase 3
701
Graz, Innsbruck, Linz, Salzburg, Sankt Pölten, Vienna, Wels
2022-12-08
Recruiting
Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty
NCT05679232Arthritis, Traumatic Arthritis, Avascular Necrosis
Medacta International SA
Not applicable
56
Vienna
2022-12-06
Active, closed
University Hospital, Tours
Not applicable
35
Vienna
2022-12-05
Recruiting
Medical University of Vienna
Phase 4
120
Vienna
2022-12-01
By invitation
Ionis Pharmaceuticals, Inc.
Phase 3
1,400
Graz, Innsbruck, Vienna
2022-11-30
Recruiting
Pfizer
Phase 3
1,060
Sankt Pölten, Vienna, Graz, Linz, Wels, Rankweil, Salzburg
2022-11-10
Active, closed
AstraZeneca
Phase 3
368
Vienna, Wels
2022-11-10
Recruiting
Bayer
Phase 3
100
Vienna, Graz, Innsbruck
2022-11-08
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
822
Graz, Innsbruck, Salzburg, Vienna
2022-11-08
Recruiting
The CATALINA Study
NCT05008081Chronic Obstructive Pulmonary Disease Exacerbation
Wim Janssens
Observational
1,000
Linz, Vienna
2022-10-25
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Linz, Salzburg, Vienna
2022-10-25
Active, closed
Berotralstat Treatment in Children With Hereditary Angioedema
NCT05453968Hereditary Angioedema, Pediatric
DrugBerotralstat
BioCryst Pharmaceuticals
Phase 3
29
Vienna
2022-10-25
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Wels, Salzburg, Vienna, Wiener Neustadt
2022-10-24
Active, closed
AbbVie
Observational
400
Vienna, Linz, Salzburg
2022-10-20
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Vienna, Salzburg
2022-10-14
Active, closed
Role of Metformin in Posterior Capsule Opacification
NCT07176338Cataract, Diabetes Mellitus Type 2
Vienna Institute for Research in Ocular Surgery
Not applicable
40
Vienna
2022-10-12
Recruiting
GBG Forschungs GmbH
Observational
400
Innsbruck, Wels, Graz, Linz, Salzburg, Vienna
2022-10-12
Active, closed
Gilead Sciences
Phase 3
1,021
Linz, Vienna, Wels
2022-10-12
Active, closed
Eli Lilly and Company
Phase 3
15,374
Feldkirch, Graz, Innsbruck, Vienna
2022-10-11
Recruiting
EMD Serono Research & Development Institute, Inc.
Observational
700
Klagenfurt, Salzburg, Vienna
2022-10-04
Active, closed
Eli Lilly and Company
Phase 3
8,000
Graz, Salzburg, Schwaz, Vienna
2022-10-04
Recruiting
Ketamine in OCD: Efficacy and Effects on Stress and Cognition
NCT05577585Obsessive-Compulsive Disorder, Psychiatric Disorder
DrugMidazolam
Medical University of Vienna
Not applicable
60
Vienna
2022-10-01
Active, closed
PedAL BCU, LLC
Phase 3
120
Vienna
2022-10-01
Recruiting
Celgene
Phase 3
810
Vienna, Krems, Leoben, Sankt Pölten
2022-09-20
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Salzburg, Vienna, Wels
2022-09-19
Recruiting
University of Ulm
Phase 3
650
Innsbruck, Linz, Rankweil, Salzburg, Vienna
2022-09-13
Active, closed
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
NCT05399992Primary Hypercholesterolemia, Mixed Dyslipidemia
Novartis Pharmaceuticals
Observational
847
Feldkirch, Graz, Linz, Sankt Veit im Pongau, Vienna
2022-09-12
Active, closed
European Myeloma Network B.V.
Phase 3
1,594
Feldkirch, Innsbruck, Krems, Linz, Salzburg, Vienna
2022-09-08
Active, closed
Redx Pharma Ltd
Phase 2
48
Vienna
2022-09-08
Recruiting
Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
NCT03810768Metabolomics, Critical Care, Critical Illness, Critical Illness Myopathy
Technical University of Munich
Observational
20
Vienna
2022-09-02
Recruiting
Haemoadsorption During Heart Transplantation
NCT05270902Heart Transplantation
Medical University of Vienna
Not applicable
40
Vienna
2022-09-01
Recruiting
Medical University of Vienna
Not applicable
30
Vienna
2022-09-01
By invitation
Ottawa Heart Institute Research Corporation
Observational
3,500
Vienna
2022-09-01
Recruiting
Asciminib Roll-over Study
NCT04877522Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
DrugsAsciminib single agent·Bosutinib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 4
347
Graz, Vienna
2022-08-30
Active, closed
AUVA Traumazentrum Vienna Site UKH Meidling
Phase 2
80
Vienna
2022-08-22
Recruiting
Bristol-Myers Squibb
Observational
1,700
Braunau am Inn, Graz, Innsbruck, Klagenfurt, Linz, Sankt Pölten, Vienna
2022-08-16
Recruiting
Infants With Severe Acute Respiratory Distress Syndrome: The Prone Trial
NCT05002478Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Surfactant Dysfunction, Infant
Medical University of Vienna
Not applicable
14
Vienna
2022-07-30
Active, closed
Gilead Sciences
Phase 3
443
Innsbruck, Linz, Salzburg, Sankt Pölten, Vienna
2022-07-25
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
Vienna
2022-07-22
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Salzburg, Vienna, Wels
2022-07-22
Active, closed
STAR-LIFE: a Post-market Registry on MINIject
NCT05269680Open Angle Glaucoma
iSTAR Medical
Observational
320
Graz, Salzburg, Vienna
2022-07-20
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Sankt Pölten, Graz, Innsbruck, Vienna
2022-07-14
Active, closed
Novartis Pharmaceuticals
Phase 1/2
55
Vienna
2022-07-13
Active, closed
Daiichi Sankyo
Phase 3
586
Feldkirch, Innsbruck, Klagenfurt, Vienna, Wels
2022-07-08
Recruiting
Octapharma
Phase 3
38
Vienna
2022-07-01
Active, closed
Celgene
Phase 3
939
Graz, Linz, Salzburg, Sankt Pölten, Vienna
2022-06-23
Recruiting
CytOSorb TreatMent Of Critically Ill PatientS Registry
NCT05146336Septic Shock, Acute Respiratory Distress Syndrome, Trauma, Rhabdomyolysis
CytoSorbents, Inc
Observational
3,000
Klagenfurt, Vienna
2022-06-22
Recruiting
Hop Compounds on the Immune System (VH)
NCT06286644Inflammatory Response
University of Vienna
Not applicable
14
Vienna
2022-05-30
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Vienna
2022-05-23
Recruiting
Electra Therapeutics Inc.
Phase 2/3
156
Innsbruck, Vienna
2022-05-19
Active, closed
Hoffmann-La Roche
Phase 3
188
Vienna
2022-05-19
Active, closed
Shanghai Henlius Biotech
Phase 3
511
Klagenfurt, Vienna
2022-05-17
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Innsbruck, Linz, Vienna
2022-05-03
Active, closed
Pierre Fabre Medicament
Phase 3
815
Graz, Linz, Sankt Pölten, Vienna
2022-05-02
Active, closed
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755Moderate Aortic Valve Stenosis
Medtronic Cardiovascular
Not applicable
650
Sankt Pölten, Vienna
2022-04-27
Recruiting
Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
NCT05114850Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Insufficiency, Heart Failure
P+F Products + Features GmbH
Observational
450
Sankt Pölten, Vienna
2022-04-20
Active, closed
Protagonist Therapeutics, Inc.
Phase 3
293
Graz, Linz, Vienna, Wels
2022-04-11
Recruiting
Medical University of Vienna
Not applicable
8
Vienna
2022-04-01
Recruiting
The DRAGON 2 Trial
NCT05428735Colorectal Cancer Liver Metastases (CRLM), Small Future Liver Remnant (FLR)
Maastricht University
Not applicable
348
Vienna
2022-04-01
Recruiting
AbbVie
Phase 2
75
Sankt Pölten, Vienna, Leoben, Linz, Salzburg
2022-03-28
Active, closed
Bayer
Phase 3
219
Vienna, Graz, Innsbruck
2022-03-28
Recruiting
MicroPort CRM
Observational
206
Krems, Vienna
2022-03-25
Recruiting
AbbVie
Phase 3
768
Vienna, Innsbruck, Linz, Wels, Feldkirch, Salzburg
2022-03-25
Active, closed
Pfizer
Phase 3
854
Vienna
2022-03-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Graz, Linz, Vienna
2022-03-24
Active, closed
Sanofi
Phase 3
122
Vienna
2022-03-11
Active, closed
BeOne Medicines
Phase 3
799
Innsbruck, Sankt Pölten, Vienna
2022-03-10
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Schwaz, Graz, Linz, Vienna
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Klagenfurt, Vienna
2022-03-04
Active, closed
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT05243550Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder
UroGen Pharma Ltd.
Phase 3
240
Vienna
2022-03-01
Recruiting
Medial Displacement Calcaneal Osteotomy and FDL- Transfer - With a Human, Allogeneic Cortical Bone Screw
NCT05643079Flat Feet, Flexor Tendon Rupture, Tibialis Posterior Dysfunction, Deformity, Foot
Orthopedic Hospital Vienna Speising
Observational
40
Vienna
2022-02-10
Active, closed
Jena University Hospital
Not applicable
230
Vienna
2022-02-10
Active, closed
Optimized CT-imaging Protocol in VA-ECMO Patients After CPR
NCT05290805Cardiopulmonary Arrest, VA-ECMO
Medical University of Vienna
Not applicable
50
Vienna
2022-02-01
Recruiting
Alexandra Kautzky-Willer
Phase 4
32
Vienna
2022-01-25
Recruiting
The "Global Paradise System" Registry
NCT05027685Hypertension
ReCor Medical, Inc.
Observational
3,000
Vienna, Wels
2022-01-13
Recruiting
Medical University of Vienna
Observational
300
Vienna
2022-01-10
Recruiting
Azienda Ospedaliero-Universitaria Careggi
Observational
10,000
Vienna
2022-01-10
Recruiting
EUROSETS ECMO Study in Clinical Extracorporeal Life Support Applications
NCT05163925Extracorporeal Membrane Oxygenation Complication
Eurosets S.r.l.
Observational
30
Vienna
2022-01-10
Recruiting
Predictive and Advanced Analytics in Emergency Medicine - Neurological Deficits
NCT06245694Artificial Intelligence, Resource Allocation, Neurologic Manifestations
Medical University of Vienna
Observational
50,000
Vienna
2022-01-01
Active, closed
Eli Lilly and Company
Phase 3
152
Feldkirch, Vienna
2021-12-20
Active, closed
MED-EL Elektromedizinische Geräte GmbH
Observational
384
Vienna
2021-12-16
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Graz, Salzburg, Vienna, Wein
2021-12-14
Recruiting
Intraindividual Comparison of EMO IOLs
NCT05822089Age Related Cataracts
Medical University of Vienna
Not applicable
461
Vienna
2021-12-13
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Graz, Innsbruck, Linz, Vienna
2021-12-10
Active, closed
Sanofi
Phase 2
22
Vienna
2021-12-07
Active, closed
Abivax S.A.
Phase 2
203
Innsbruck, Vienna
2021-12-03
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
256
Leoben, Vienna
2021-11-18
Active, closed
Gilead Sciences
Phase 3
603
Innsbruck, Salzburg, Vienna
2021-11-17
Recruiting
Insel Gruppe AG, University Hospital Bern
Phase 3
70
Innsbruck, Linz, Vienna
2021-11-16
Recruiting
Medical University of Vienna
Observational
300
Vienna
2021-11-11
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
NCT04996875Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN), Mast Cell Leukemia (MCL), Aggressive Systemic Mastocytosis (ASM)
DrugBezuclastinib
Cogent Biosciences, Inc.
Phase 2
140
Vienna
2021-11-09
Active, closed
Amgen
Phase 3
303
Graz, Innsbruck, Linz, Vienna
2021-11-02
Active, closed
Pre-op Fluid Study
NCT05079269Hypotension Drug-Induced, Anesthesia
Medical University of Graz
Not applicable
550
Vienna, Graz
2021-11-01
Active, closed
AstraZeneca
Phase 3
454
Linz, Vienna
2021-10-28
Active, closed
GWT-TUD GmbH
Phase 3
70
Innsbruck, Vienna
2021-10-27
Active, closed
argenx
Phase 2/3
15
Vienna
2021-10-26
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
26
Vienna
2021-10-20
Active, closed
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase 2
198
Kufstein, Leoben, Mitterweng, Salzburg, Sankt Pölten, Vienna, Zams
2021-10-20
Recruiting
Medical University of Vienna
Observational
140
Vienna
2021-10-15
Recruiting
Niguarda Hospital
Phase 3
288
Graz, Innsbruck, Vienna
2021-10-07
Active, closed
Novartis Pharmaceuticals
Phase 3
129
Vienna
2021-10-05
Recruiting
Pfizer
Phase 3
893
Krems, Vienna, Innsbruck, Salzburg
2021-10-04
Active, closed
Eli Lilly and Company
Phase 3
874
Vienna, Graz, Salzburg
2021-10-04
Active, closed
Safe and Timely Antithrombotic Removal (STAR) Registry
NCT05077124Hemorrhage, Surgical, Hemorrhage Postoperative, Blood Loss, Surgical, Blood Loss, Postoperative
CytoSorbents, Inc
Observational
1,000
Graz, Innsbruck, Vienna
2021-09-30
Active, closed
Loxo Oncology, Inc.
Phase 3
282
Salzburg, Vienna
2021-09-23
Recruiting
Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps
NCT05009758Asthma, Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis), Nasal Polyps
Medical University of Vienna
Not applicable
30
Vienna
2021-09-01
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Graz, Innsbruck, Rankweil, Salzburg, Sankt Pölten, Sankt Veit im Pongau, Steyr, Vienna
2021-08-27
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Graz, Linz, Vienna
2021-08-25
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
110
Vienna
2021-08-19
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Graz, Linz, Salzburg, Vienna
2021-08-19
Active, closed
Christian Buske
Phase 2
99
Salzburg, Vienna
2021-08-18
Recruiting
Miltenyi Biomedicine GmbH
Phase 2
213
Graz, Innsbruck, Linz, Vienna
2021-08-18
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Graz, Klagenfurt, Sankt Pölten, Vienna
2021-08-14
Active, closed
AstraZeneca
Phase 3
712
Graz, Krems, Linz, Vienna, Wiener Neustadt
2021-08-05
Active, closed
Boston Scientific Corporation
Phase 4
544
Innsbruck, Sankt Pölten, Vienna
2021-08-02
Recruiting
Medical University of Vienna
Observational
90
Vienna
2021-07-26
Recruiting
Comparison of Computertomography Scan, Electrical Impedance Tomography, and Ultrasound of the Lung in Infants
NCT04989439Infant ALL, Computed Tomography, Electric Impedance, Ultrasonography
Medical University of Vienna
Observational
10
Vienna
2021-07-19
Active, closed
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
NCT04554914Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD)
DrugTabelecleucel
Pierre Fabre Medicament
Phase 2
190
Salzburg, Vienna, Graz
2021-07-14
Active, closed
Hoffmann-La Roche
Phase 3
451
Graz, Vienna
2021-07-14
Recruiting
Valved Graft PMCF Study
NCT04754217Aortic Valve Disease, Ascending Aorta Abnormality, Aortic Dissection
Abbott Medical Devices
Observational
260
Vienna
2021-07-13
Active, closed
Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation
NCT04788888Symptomatic Severe Aortic Stenosis
Abbott Medical Devices
Not applicable
434
Linz, Vienna
2021-07-13
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
European Foundation for Study of Chronic Liver Failure
Observational
3,000
Vienna
2021-07-08
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 3
434
Graz, Innsbruck, Klagenfurt, Linz, Sankt Pölten, Vienna
2021-07-06
Active, closed
Medical University of Vienna
Observational
350
Vienna
2021-07-01
Recruiting
A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD
NCT04201210HbS Disease, Hemoglobin S Disease, Sickle Cell Anemia, Sickle Cell Disorders
University of Regensburg
Phase 2
212
Vienna
2021-06-30
Active, closed
AstraZeneca
Phase 3
315
Graz, Innsbruck, Salzburg, Vienna
2021-06-30
Active, closed
GlaxoSmithKline
Phase 3
40
Feldkirch, Innsbruck, Steyr, Vienna
2021-06-28
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Innsbruck, Vienna, Wiener Neustadt
2021-06-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Wiener Neustadt, Vienna, Graz, Innsbruck, Salzburg
2021-06-18
Active, closed
Novartis Pharmaceuticals
Phase 3
1,144
Innsbruck, Linz, Vienna
2021-06-09
Recruiting
Medical University of Vienna
Observational
700
Vienna
2021-06-01
Recruiting
Medical University of Vienna
Not applicable
48
Vienna
2021-06-01
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
150
Vienna
2021-05-26
Active, closed
Nobel Biocare
Observational
1,000
Vienna
2021-05-26
Recruiting
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
NCT04503395Aortic Aneurysm, Abdominal
FCRE (Foundation for Cardiovascular Research and Education)
Not applicable
204
Vienna
2021-05-21
Active, closed
Incyte Corporation
Phase 3
899
Innsbruck, Linz, Rankweil, Sankt Pölten, Vienna
2021-05-11
Active, closed
Hoffmann-La Roche
Observational
800
Klagenfurt, Vienna
2021-05-10
Active, closed
Hoffmann-La Roche
Phase 2
586
Graz, Innsbruck, Vienna
2021-05-05
Recruiting
Erasmus Medical Center
Not applicable
600
Vienna
2021-05-01
Recruiting
Ipsen
Phase 1/2
240
Innsbruck, Linz, Vienna
2021-04-29
Active, closed
Hoffmann-La Roche
Phase 3
557
Innsbruck, Salzburg, Sankt Pölten, Vienna
2021-04-26
Recruiting
GlaxoSmithKline
Phase 2
37
Graz, Vienna
2021-04-16
Active, closed
Incyte Corporation
Phase 3
654
Graz, Innsbruck, Linz, Vienna
2021-04-15
Recruiting
Tendyne European Experience Registry
NCT04898335Mitral Regurgitation
LMU Klinikum
Observational
400
Linz, Vienna
2021-04-15
Active, closed
Takeda
Phase 3
77
Vienna
2021-04-14
Active, closed
Jena University Hospital
Not applicable
478
Vienna, Graz, Klagenfurt
2021-04-13
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Graz, Saint Stefan, Salzburg, Vienna, Wels
2021-04-01
Recruiting
Maastricht University Medical Center
Observational
350
Vienna
2021-03-16
Recruiting
Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C
NCT05035693Discopathy, Herniated Cervical Disc, Stenoses, Spinal, Radiculopathy
NGMedical GmbH
Not applicable
170
Vienna
2021-03-11
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Salzburg, Linz, Vienna
2021-03-09
Active, closed
German CLL Study Group
Phase 3
897
Graz, Innsbruck, Vienna
2021-03-01
Recruiting
Medical University of Vienna
Phase 4
290
Vienna
2021-03-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Vienna, Graz, Linz
2021-02-25
Active, closed
Celgene
Phase 3
313
Graz, Linz, Vienna
2021-02-25
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Klagenfurt, Salzburg, Vienna
2021-02-23
Active, closed
Hoffmann-La Roche
Phase 3
55
Vienna
2021-02-04
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
277
Vienna
2021-02-02
Recruiting
Epygon
Not applicable
40
Innsbruck, Vienna
2021-02-01
Recruiting
SCAD : a Registry of Spontaneous Coronary Artery Dissection
NCT06601270Spontaneous Coronary Artery Dissection
European Society of Cardiology
Observational
1,500
Innsbruck, Vienna, Wiener Neustadt
2021-01-30
Active, closed
AstraZeneca
Phase 3
1,371
Feldkirch, Salzburg, Vienna
2021-01-28
Active, closed
Galderma R&D
Phase 3
500
Graz, Linz, Vienna
2021-01-11
Active, closed
Amgen
Phase 1/2
181
Vienna
2021-01-04
Recruiting
Real-Life Chronic Rhinosinusitis Outcome Registry
NCT04670172Chronic Rhinosinusitis (Diagnosis)
Change Accelerator in Respiratory Care
Observational
4,550
Graz, Vienna
2021-01-01
Active, closed
AstraZeneca
Phase 3
358
Graz, Vienna
2020-12-16
Active, closed
Neurocrine Biosciences
Phase 3
182
Graz, Vienna
2020-12-16
Active, closed
Universität Münster
Phase 2
190
Innsbruck, Linz, Salzburg, Vienna
2020-12-10
Active, closed
Stroke-Card Registry
NCT04582825Ischemic Stroke, Transient Ischemic Attack
VASCage GmbH
Observational
5,000
Vienna, Innsbruck
2020-12-09
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Linz, Salzburg, Vienna
2020-12-07
Active, closed
JOTEC GmbH
Observational
163
Vienna
2020-12-03
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Klagenfurt, Krems, Linz, Vienna
2020-12-02
Active, closed
University Hospital, Basel, Switzerland
Not applicable
64,374
Vienna
2020-12-01
Active, closed
XVIVO Perfusion
Not applicable
230
Vienna
2020-11-25
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Linz, Salzburg, Vienna
2020-11-12
Active, closed
Bayer
Phase 4
654
Vienna, Linz
2020-11-09
Recruiting
Vyxeos® With Clofarabine for Pediatric AML
NCT07156435Relapsed Pediatric AML, Refractory Pediatric AML
DrugClofarabine
Princess Maxima Center for Pediatric Oncology
Phase 1
25
Vienna
2020-11-06
Recruiting
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
NCT04111978Ovarian Neoplasm Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms, High-grade Serous Ovarian Carcinoma (HGSOC)
DrugLetrozole
Swiss GO Trial Group
Phase 3
540
Graz, Innsbruck, Leoben, Linz, Salzburg, Vienna
2020-11-05
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Linz, Vienna
2020-11-03
Recruiting
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
NCT04688190Mitral Regurgitation, Mitral Valve Disease, Mitral Annular Calcification
Universitätsklinikum Hamburg-Eppendorf
Observational
1,000
Vienna
2020-11-01
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565HER2-negative Breast Cancer, Triple Negative Breast Cancer
DrugsXeloda·Sacituzumab Govitecan·Paraplatin·Capecitabine
GBG Forschungs GmbH
Phase 3
1,332
Graz, Innsbruck, Linz, Salzburg, Sankt Pölten, Vienna, Vöcklabruck, Wels
2020-10-28
Active, closed
Pfizer
Observational
1,407
Braunau am Inn, Innsbruck, Klagenfurt, Salzburg, Sankt Pölten, Schwaz, Vienna
2020-10-27
Active, closed
Hoffmann-La Roche
Phase 3
985
Linz, Vienna
2020-10-26
By invitation
Novo Nordisk A/S
Observational
60
Vienna
2020-10-23
Active, closed
Bayer
Phase 3
774
Vienna
2020-10-20
Active, closed
Exelixis
Phase 3
575
Linz, Vienna
2020-10-19
Active, closed
Hoffmann-La Roche
Phase 3
992
Salzburg, Steyr, Vienna
2020-10-09
Recruiting
CGRP Inhibition, Autonomic Function, and Migraine
NCT04628429Episodic Migraine, Chronic Migraine
DrugsErenumab·Fremanezumab·Galcanezumab
Medical University of Vienna
Observational
120
Vienna
2020-10-01
Recruiting
Patient Experience Data in Radiation Oncology
NCT05224297Radiotherapy Side Effect, PROMs
Medical University of Vienna
Observational
6,000
Vienna
2020-10-01
Active, closed
AbbVie
Phase 3
527
Sankt Pölten, Vienna, Linz
2020-09-30
Active, closed
argenx
Phase 2
229
Innsbruck, Linz, Vienna
2020-09-18
Recruiting
University of Birmingham
Phase 1/2
1,672
Linz, Vienna
2020-09-17
Active, closed
AbbVie
Phase 3
531
Vienna, Linz, Wels, Salzburg
2020-09-10
Recruiting
Pierre Fabre Pharma GmbH
Observational
500
Braunau am Inn, Linz, Feldkirch, Vienna
2020-09-03
Recruiting
Isabelle Opitz, Professor, MD
Not applicable
120
Vienna
2020-09-01
Active, closed
AbbVie
Phase 3
330
Sankt Pölten, Vienna, Graz, Linz, Wels
2020-08-31
Recruiting
Malmö University
Observational
650
Vienna
2020-08-30
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Linz, Vienna
2020-08-25
Active, closed
Incyte Corporation
Phase 2
112
Vienna
2020-08-03
Active, closed
University Hospital, Basel, Switzerland
Not applicable
382
Salzburg, Vienna
2020-07-28
Active, closed
Celgene
Phase 2
276
Vienna
2020-07-14
Recruiting
Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps
NCT04641416End-stage Heart Failure, Cardiomyopathies, Mechanical Circulatory Support
Thomas Schlöglhofer, PhD, MSc
Observational
60
Vienna
2020-07-09
Active, closed
RETHINK REFLUX Registry
NCT04253392Gastroesophageal Reflux
Ethicon Endo-Surgery
Observational
500
Vienna
2020-07-08
Active, closed
Supramarginal Resection in Glioblastoma
NCT04243005Glioblastoma
St. Olavs Hospital
Not applicable
90
Vienna
2020-07-01
Recruiting
Vienna HIV Infection Via Sex Study
NCT05326061HIV Infections, HIV Pre-Exposure Prophylaxis, Sexually Transmitted Diseases, Gonorrhea
Medical University of Vienna
Observational
500
Vienna
2020-07-01
Active, closed
Actelion
Phase 3
935
Graz, Linz, Vienna
2020-06-30
Active, closed
SAPIEN 3 Ultra System PMCF
NCT04555967Aortic Valve Stenosis
Edwards Lifesciences
Observational
200
Vienna
2020-06-30
Active, closed
Eli Lilly and Company
Phase 3
996
Salzburg, Vienna, Innsbruck
2020-06-22
Recruiting
International CIPN Assessment and Validation Study
NCT04633655Chemotherapy-induced Peripheral Neuropathy, Quality of Life
University of Milano Bicocca
Observational
1,000
Vienna
2020-06-08
Recruiting
University Hospital Heidelberg
Phase 1/2
91
Vienna
2020-05-26
Recruiting
Karl Landsteiner Institute for Lung Research and Pneumological Oncology
Observational
500
Vienna
2020-04-17
Recruiting
Medical University of Vienna
Not applicable
108
Vienna
2020-03-09
Recruiting
German CLL Study Group
Phase 2
83
Vienna
2020-02-19
Active, closed
KANDO Research
Not applicable
302
Graz, Vienna
2020-02-18
By invitation
Global Utilization And Registry Database for Improved heArt preservatioN
NCT04141605Heart Diseases, Heart Failure, Heart Defects, Congenital
Paragonix Technologies
Observational
4,000
Graz, Vienna
2020-02-14
Recruiting
Medtronic Cardiac Surgery
Observational
5,000
Vienna
2020-01-09
Active, closed
CMR-AI and Outcomes in AS
NCT06128876Aortic Stenosis
Medical University of Vienna
Observational
1,500
Vienna
2020-01-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Graz, Innsbruck, Linz, Salzburg, Vienna
2019-12-20
Active, closed
Christian Buske
Phase 2
36
Vienna
2019-12-15
Active, closed
Cold Agglutinin Disease Real World Evidence Registry
NCT05791708Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS)
RECORDATI GROUP
Observational
429
Salzburg, Vienna
2019-12-12
Recruiting
Alexion Pharmaceuticals, Inc.
Observational
500
Vienna
2019-12-02
Recruiting
Medtronic Cardiac Surgery PMCF Registry
NCT04073420Valve Disease, Heart
Medtronic Cardiac Surgery
Observational
2,700
Vienna
2019-12-02
Active, closed
Alnylam Pharmaceuticals
Phase 3
655
Graz, Vienna
2019-11-26
Recruiting
Medical University of Vienna
Observational
30
Vienna
2019-11-18
Active, closed
Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia
NCT04232241Acute Myeloid Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, Myelodysplastic Syndromes
Universitätsklinikum Hamburg-Eppendorf
Phase 2
167
Graz, Innsbruck, Vienna
2019-11-14
Recruiting
APrevent Biotech GmbH
Not applicable
30
Vienna
2019-11-13
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
DrugsDinutuximab beta·Vindesine·Cyclophosphamid·Thiotepa
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Graz, Innsbruck, Linz, Salzburg, Vienna
2019-11-05
By invitation
Rigel Pharmaceuticals
Phase 3
90
Vienna
2019-10-30
Active, closed
Bristol-Myers Squibb
Phase 3
790
Graz, Innsbruck, Salzburg, Vienna
2019-10-28
Active, closed
University of Southampton
Observational
429
Vienna
2019-10-28
Active, closed
Novo Nordisk A/S
Phase 3
134
Vienna
2019-10-21
Recruiting
Pierre Fabre Pharma GmbH
Observational
750
Graz, Innsbruck, Klagenfurt, Linz, Salzburg, Vienna, Wiener Neustadt
2019-10-17
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Innsbruck, Vienna
2019-10-02
Active, closed
University of Zurich
Observational
540
Vienna
2019-10-01
Active, closed
RECORDATI GROUP
Observational
125
Vienna
2019-09-30
By invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
NCT04093570Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
DrugDecitabine
Taiho Oncology, Inc.
Phase 2
332
Vienna
2019-09-30
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Innsbruck, Linz, Vienna
2019-09-23
Active, closed
Pfizer
Phase 3
896
Vienna
2019-09-05
Active, closed
University of Ulm
Phase 3
882
Graz, Innsbruck, Linz, Rankweil, Salzburg, Vienna
2019-09-04
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
Graz, Innsbruck, Salzburg, Vienna
2019-08-27
Recruiting
University Hospital Muenster
Phase 3
683
Graz, Innsbruck, Linz, Salzburg, Vienna
2019-08-23
Active, closed
MiCLASP Post Market Clinical Follow-Up (PMCF) Study
NCT04430075Mitral Regurgitation, Mitral Insufficiency
Edwards Lifesciences
Observational
1,000
Vienna
2019-08-23
Active, closed
BeOne Medicines
Phase 3
510
Linz, Salzburg, Vienna
2019-08-20
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Graz, Linz, Sankt Pölten, Vienna, Wels
2019-08-09
Active, closed
Bristol-Myers Squibb
Phase 3
839
Graz, Linz, Salzburg, Vienna, Wiener Neustadt
2019-08-05
Active, closed
Thomas Wekerle
Phase 1/2
12
Vienna
2019-08-01
Active, closed
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
NCT03960840Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia
DrugIbrutinib
Novartis Pharmaceuticals
Phase 1/2
218
Vienna
2019-06-26
Active, closed
Exelixis
Phase 3
855
Wiener Neustadt, Linz, Salzburg, Vienna
2019-06-25
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Graz, Linz, Vienna
2019-06-24
Active, closed
Bristol-Myers Squibb
Phase 3
437
Graz, Vienna, Wels
2019-06-21
Active, closed
Sanofi
Observational
955
Graz, Linz, Maria Enzersdorf, Vienna
2019-06-11
Recruiting
Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)
NCT03627013Kidney Failure, Liver Failure, Chronic, Kidney-Pancreas Failure
DrugCustodiol-N
Dr. F. Köhler Chemie GmbH
Phase 3
362
Graz, Innsbruck, Linz, Vienna
2019-05-23
Active, closed
Nuvaira, Inc.
Not applicable
464
Vienna
2019-05-23
Active, closed
Celgene
Phase 1/2
438
Salzburg, Sankt Pölten, Vienna
2019-05-20
Active, closed
Inspiris Resilia Durability Registry
NCT03666741Aortic Valve Stenosis
Institut für Pharmakologie und Präventive Medizin
Observational
400
Sankt Pölten, Vienna
2019-04-26
By invitation
Novo Nordisk A/S
Observational
60
Vienna
2019-04-01
Active, closed
Automatic PredICtion of Edema After Stroke
NCT04057690Stroke, Acute, Brain Edema
University Hospital Tuebingen
Observational
1,687
Vienna
2019-04-01
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Klagenfurt, Vienna, Linz, Salzburg, Sankt Pölten, Wels
2019-03-28
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Graz, Innsbruck, Linz, Salzburg, Sankt Pölten, Vienna
2019-03-21
Active, closed
Medical University of Vienna
Not applicable
60
Vienna
2019-03-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Graz, Innsbruck, Linz, Vienna
2019-03-01
Active, closed
Acerta Pharma BV
Phase 3
984
Krems, Salzburg, Vienna
2019-02-25
Recruiting
Medical University of Vienna
Not applicable
750
Vienna
2019-01-21
Recruiting
Cold-induced Brown Fat Activation and Hepatic Steatosis
NCT03811236Non-Alcoholic Fatty Liver Disease
Medical University of Vienna
Not applicable
26
Vienna
2019-01-21
Active, closed
AstraZeneca
Phase 3
1,407
Graz, Innsbruck, Linz, Vienna
2019-01-04
Active, closed
Celgene
Phase 3
363
Linz, Vienna
2019-01-02
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Vienna
2018-12-28
Active, closed
AstraZeneca
Phase 1
175
Salzburg, Vienna
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Vienna, Innsbruck, Linz, Salzburg
2018-12-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Graz, Linz, Salzburg, Vienna
2018-12-17
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Innsbruck, Graz, Linz, Salzburg, Vienna
2018-12-07
Active, closed
AstraZeneca
Phase 3
825
Graz, Innsbruck, Rankweil, Vienna
2018-12-06
Recruiting
Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study
NCT03921931Macular Degeneration, Dry, Primary Open-angle Glaucoma
Medical University of Vienna
Not applicable
35
Vienna
2018-11-26
Recruiting
Medical University of Vienna
Not applicable
120
Vienna
2018-11-21
Recruiting
Medical University of Vienna
Not applicable
20
Vienna
2018-11-19
Active, closed
Exelixis
Phase 3
187
Salzburg, Vienna
2018-10-05
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
DrugsPonatinib·Imatinib·Cytarabine·Methotrexate
Takeda
Phase 3
245
Vienna, Linz
2018-10-04
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Graz, Vienna
2018-09-20
Active, closed
Fondazione Michelangelo
Phase 3
650
Klagenfurt, Linz, Sankt Pölten, Vienna
2018-09-07
Active, closed
AbbVie
Phase 3
1,242
Sankt Pölten, Vienna, Graz, Linz, Salzburg
2018-08-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Graz, Innsbruck, Linz, Salzburg, Vienna
2018-08-21
Active, closed
Hoffmann-La Roche
Phase 3
257
Vienna
2018-08-16
Active, closed
AbbVie
Phase 3
1,533
Vienna, Innsbruck, Linz
2018-08-09
Active, closed
University Hospital, Basel, Switzerland
Not applicable
1,500
Dornbirn, Feldkirch, Innsbruck, Linz, Salzburg, Vienna, Wels
2018-08-07
Recruiting
Christoph Arnoldner
Observational
8
Vienna
2018-08-01
Recruiting
Celgene
Phase 2/3
1,541
Linz, Vienna
2018-07-19
Active, closed
Eli Lilly and Company
Phase 3
1,058
Innsbruck, Salzburg, Vienna
2018-07-18
Recruiting
Martin Schrappe
Phase 3
5,000
Graz, Innsbruck, Linz, Salzburg, Vienna
2018-07-15
Recruiting
AtriCure, Inc.
Observational
5,000
Vienna
2018-06-29
Recruiting
University of Leipzig
Not applicable
120
Graz, Vienna
2018-06-18
Active, closed
Exelixis
Phase 3
837
Klagenfurt, Sankt Pölten, Graz, Linz, Vienna
2018-06-10
Active, closed
AstraZeneca
Phase 3
1,018
Graz, Innsbruck, Linz, Salzburg, Vienna
2018-05-14
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Linz, Sankt Pölten, Vienna
2018-05-14
Active, closed
Corcept Therapeutics
Phase 2
125
Vienna
2018-05-07
Active, closed
GlaxoSmithKline
Phase 2
237
Linz, Vienna
2018-05-03
Active, closed
Bristol-Myers Squibb
Phase 3
545
Graz, Vienna
2018-04-18
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Salzburg, Vienna
2018-04-13
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Graz, Salzburg, Vienna
2018-04-11
Active, closed
AbbVie
Phase 3
1,336
Sankt Pölten, Vienna, Graz
2018-04-09
Recruiting
Thomas Reiberger
Observational
400
Vienna
2018-03-28
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Graz, Linz, Salzburg, Vienna
2018-03-23
Recruiting
Post-Market BTVA Registry
NCT03318406Emphysema or COPD
Uptake Medical Technology, Inc.
Observational
300
Vienna
2018-03-22
Active, closed
AbbVie
Phase 3
747
Vienna, Salzburg
2018-03-21
Active, closed
Bentley InnoMed GmbH
Not applicable
18
Vienna
2018-03-01
Recruiting
Retinal Neuro-vascular Coupling in Patients With Multiple Sclerosis
NCT03401879Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
Medical University of Vienna
Not applicable
50
Vienna
2018-02-01
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006Coronary Artery Disease, Heart Diseases
Weill Medical College of Cornell University
Not applicable
4,300
Innsbruck, Vienna
2018-01-07
Recruiting
Vienna Hypothermic Oxygenated Machine Perfusion Study
NCT06418165End Stage Liver Disease, Hepatocellular Carcinoma
Medical University of Vienna
Observational
500
Vienna
2018-01-01
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
Vienna
2017-12-29
Active, closed
AstraZeneca
Phase 2
528
Innsbruck, Salzburg, Vienna
2017-12-18
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Vienna
2017-12-16
Recruiting
LivaNova
Observational
500
Vienna
2017-12-14
Recruiting
AbbVie
Observational
500
Sankt Pölten, Graz, Salzburg, Vienna
2017-12-04
Recruiting
Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects
NCT03870230Glaucoma, Open-Angle, Normal Tension Glaucoma, Ocular Hypertension
Medical University of Vienna
Not applicable
120
Vienna
2017-12-01
Recruiting
RWTH Aachen University
Phase 2
200
Vienna
2017-11-20
Recruiting
Medical University of Vienna
Observational
40
Vienna
2017-10-20
Active, closed
Medical University of Graz
Phase 3
2,400
Enzenbach, Feldbach, Graz, Klagenfurt, Leoben, Linz, Schwarzach im Pongau, Vienna
2017-10-10
Active, closed
Hoffmann-La Roche
Phase 3
382
Vienna
2017-09-20
Active, closed
Global Fenestrated Anaconda Clinical STudy
NCT03180996Abdominal Aortic Aneurysm
Vascutek Ltd.
Observational
160
Vienna
2017-09-11
Recruiting
Charite University, Berlin, Germany
Phase 2
250
Vienna
2017-09-01
Recruiting
Medical University of Vienna
Observational
340
Vienna
2017-08-31
Active, closed
Paediatric Hepatic International Tumour Trial
NCT03017326Hepatoblastoma, Carcinoma, Hepatocellular
Drugs5Fluorouracil·Sorafenib·Vincristine·Doxorubicin
University of Birmingham
Phase 3
450
Vienna
2017-08-24
Active, closed
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT03007147Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia, T Acute Lymphoblastic Leukemia
DrugsL-leucovorin·Therapeutic Hydrocortisone·Levofolinate·Isophosphamide
Children's Oncology Group
Phase 3
352
Vienna
2017-08-08
Active, closed
University Hospital Muenster
Phase 3
650
Graz, Innsbruck, Klagenfurt, Linz, Salzburg, Vienna
2017-08-03
Active, closed
The Chocolate Touch Study
NCT02924857Peripheral Artery Disease (PAD), Ischemia, Intermittent Claudication
TriReme Medical, LLC
Not applicable
333
Graz, Vienna
2017-07-26
Active, closed
Eli Lilly and Company
Phase 3
5,637
Vienna, Graz, Innsbruck, Schwaz, Salzburg
2017-07-12
Active, closed
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
NCT03173248Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS), Leukemia, Myeloid, Acute
DrugsIvosidenib·Azacitidine
Institut de Recherches Internationales Servier
Phase 3
146
Salzburg, Vienna
2017-06-26
Recruiting
Swiss Paediatric Airway Cohort
NCT03505216Asthma, Wheezing, Cough, Exercise Induced Bronchospasm
University of Bern
Observational
6,000
Vienna
2017-06-06
Recruiting
Medical University of Vienna
Observational
300
Vienna
2017-05-30
Recruiting
Intraoperative EABR for Decision Making
NCT03745560Vestibular Schwannoma, Hearing Loss
Christoph Arnoldner
Observational
15
Vienna
2017-05-23
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Vienna
2017-05-03
Active, closed
AstraZeneca
Phase 3
987
Linz, Salzburg, Vienna
2017-03-27
Recruiting
Medical University of Vienna
Not applicable
12
Vienna
2017-03-23
Recruiting
Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin
NCT04204837Squamous Cell Carcinoma of the Skin
DrugsRelatlimab·Nivolumab
Salzburger Landeskliniken
Phase 2
61
Graz, Innsbruck, Klagenfurt, Salzburg, Sankt Pölten, Vienna, Wels
2017-03-06
Active, closed
Persona Partial Knee Clinical Outcomes Study
NCT03034811Osteoarthritis, Avascular Necrosis, Traumatic Arthritis, Conditional Tibial Condyle or Plateau Fractures
Zimmer Biomet
Not applicable
757
Vienna
2017-02-08
Active, closed
ITM Solucin GmbH
Phase 3
324
Vienna
2017-02-02
Active, closed
AbbVie
Phase 3
443
Sankt Pölten, Graz, Linz, Salzburg, Vienna
2017-02-02
Active, closed
Acerta Pharma BV
Phase 3
310
Linz, Salzburg, Vienna, Wels
2017-02-02
Recruiting
VICIS - Vienna Cirrhosis Study
NCT03267615Liver Cirrhosis, Portal Hypertension, Ascites, Variceal Hemorrhage
Medical University of Vienna
Observational
10,000
Vienna
2017-02-01
Active, closed
AbbVie
Phase 3
950
Vienna, Linz, Salzburg
2017-01-31
Active, closed
Noninvasive Mapping Before Surgical Ablation
NCT06803615Atrial Fibrillation (AF)
Medical University of Vienna
Observational
51
Vienna
2017-01-13
Active, closed
IRCCS San Raffaele
Observational
1,402
Graz, Vienna
2017-01-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Vienna
2016-12-22
Active, closed
Janssen Biotech, Inc.
Observational
535
Salzburg, Sankt Poelten Noe, Vienna
2016-12-16
Recruiting
Fosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis, Central Nervous System Bacterial Infections
Infectopharm Arzneimittel GmbH
Observational
1,000
Hall in Tirol, Reutte, Vienna, Wels
2016-12
Active, closed
Eisai Inc.
Phase 3
1,069
Innsbruck, Linz, Vienna
2016-10-13
Recruiting
Medical University of Vienna
Not applicable
200
Vienna
2016-08
Active, closed
AGO Study Group
Not applicable
797
Vienna
2016-07
Active, closed
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer
NCT03469674Endometrial Cancer Stage I, Endometrial Cancer Stage II
Leiden University Medical Center
Phase 3
550
Vienna
2016-06-10
Active, closed
Eli Lilly and Company
Phase 2
309
Wiener Neustadt, Salzburg, Vienna
2016-05-19
Recruiting
University of Alberta
Observational
700
Vienna
2016-05
Active, closed
The PREWEAN Study. Weaning of Preterm Infants During the First Year of Life.
NCT02936219Growth Failure, Atopy, Adiposity, Cognitive Impairment
Medical University of Vienna
Observational
218
Vienna
2016-04
Recruiting
Medical University of Vienna
Phase 2
1,000
Vienna
2016-04
Recruiting
NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
NCT02817360Heart Diseases, Diabetes Mellitus, Type 2
Martin Huelsmann
Phase 4
2,400
Mödling, Graz, Linz, Vienna
2016-02
Recruiting
University of Alberta
Observational
900
Vienna
2016-01
Recruiting
Stem Cell Ophthalmology Treatment Study II
NCT03011541Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa, Stargardt Disease
MD Stem Cells
Not applicable
500
Vienna
2016-01
Recruiting
Aflibercept in Recurrent or Persistent CNV
NCT02669953Age Related Macular Degeneration, Intravitreal Injections, Diabetic Macular Edema
DrugAflibercept
Medical University of Vienna
Observational
80
Vienna
2015-12
Active, closed
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
NCT02659215Defect of Articular Cartilage
Anika Therapeutics, Inc.
Not applicable
200
Tulln, Linz, Ried, Graz, Krems, Vienna
2015-12
Active, closed
AstraZeneca
Phase 3
1,126
Linz, Vienna
2015-11-02
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Linz, Salzburg, Vienna
2015-11-02
Active, closed
University of Rostock
Not applicable
5,505
Salzburg, Dornbirn, Graz, Linz, Saint Veit/Glan, Vienna, Wolfsberg
2015-09
Active, closed
Smith & Nephew, Inc.
Observational
163
Vienna
2015-09
Recruiting
The Medacta International SMS Post-Marketing Surveillance Study
NCT02748408Arthrosis, Traumatic Arthritis, Rheumatoid Polyarthritis, Congenital Hip Dysplasia
Medacta International SA
Observational
550
Vienna
2015-07
Recruiting
Metastatic Breast Cancer in Austria
NCT03870620Breast Cancer, Breast Carcinoma, Breast Tumor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Observational
5,000
Salzburg, Vienna, Graz, Innsbruck, Kufstein, Linz, Steyr, Wels
2015-06-15
Recruiting
Surgery for Recurrent Glioblastoma
NCT02394626Glioblastoma
Insel Gruppe AG, University Hospital Bern
Phase 2
120
Innsbruck, Linz, Vienna
2015-05-01
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Graz, Linz, Vienna
2015-04-22
Active, closed
Pfizer
Phase 3
1,068
Linz, Vienna, Salzburg
2014-12-17
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
Graz, Innsbruck, Salzburg, Vienna
2014-12-04
Active, closed
Eli Lilly and Company
Phase 3
493
Vienna, Graz, Innsbruck, Linz
2014-11-06
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Graz, Innsbruck, Leoben, Linz, Salzburg, Vienna
2014-11
Recruiting
Atrial Fibrillation at the Viennese University Emergency Department
NCT03272620Atrial Fibrillation, Atrial Flutter
Medical University of Vienna
Observational
3,000
Vienna
2014-10-22
Recruiting
Cerebellar Mutism Syndrome Study
NCT02300766Infratentorial Neoplasms, Mutism
Copenhagen University Hospital, Rigshospitalet
Observational
2,000
Vienna
2014-10
Recruiting
Medical University of Vienna
Not applicable
400
Vienna
2014-06
Recruiting
Medical University of Vienna
Not applicable
120
Vienna
2014-06
Recruiting
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
NCT02979119Factor VIII Deficiency, Factor IX Deficiency
PedNet Haemophilia Research Foundation
Observational
4,000
Graz, Vienna
2014-06
Recruiting
Medical University of Vienna
Not applicable
12
Vienna
2014-05
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 3
789
Vienna
2014-04
Recruiting
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
NCT01356290Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent, Rare CNS Tumor Recurrent
DrugsThalidomide·Celecoxib·Temozolomide·Cytarabine
Medical University of Vienna
Phase 2
232
Graz, Innsbruck, Linz, Salzburg, Vienna
2014-04
Active, closed
Zimmer POLAR Persona - TKA (EMEA Study)
NCT02337244Severe Knee Pain, Severe Knee Disability, Osteoarthritis, Rheumatoid Arthritis
Zimmer, GmbH
Observational
777
Vienna
2013-11-18
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Graz, Innsbruck, Linz, Vienna
2013-10-14
Active, closed
AstraZeneca
Phase 3
510
Innsbruck, Linz, Salzburg, Vienna
2013-09-25
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Vienna
2013-07-26
Recruiting
Javier P. Gisbert
Observational
10,000
Vienna
2013-06
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Graz, Innsbruck, Vienna
2013-04
Active, closed
Survivorship of Attune Primary Total Knee Prosthesis
NCT01754363Noninflammatory Degenerative Joint Disease
DePuy International
Not applicable
1,542
Vienna, Linz
2013-02-01
Active, closed
Bristol-Myers Squibb
Observational
800
Bregenz, Innsbruck, Vienna
2013-01-30
Active, closed
Eli Lilly and Company
Phase 2
110
Vienna
2012-05-22
Active, closed
The Austrian LEAD (Lung hEart sociAl boDy) Study
NCT01727518Respiration Disorders, Body Composition, Beneficial, Metabolic Health
Ludwig Boltzmann Institute for Lung Health
Observational
14,966
Vienna
2011-10
Recruiting
Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation
NCT01299168Validation Study of Molecular Diagnostic System, Development of Reporting System for Molecular Diagnosis, Incorporate Molecular Diagnosis Into Diagnostic Standards
University of Alberta
Observational
500
Vienna
2011-05
Recruiting
International (Pediatric) Peritoneal Biobank
NCT01893710Kidney Failure, Chronic, Peritoneal Dialysis Complication, Transplantation, Healthy
Heidelberg University
Observational
500
Vienna
2011-02-01
Recruiting
International Chronic Myeloid Leukemia Pediatric Study
NCT01281735Chronic Myeloid Leukemia
Poitiers University Hospital
Observational
750
Vienna
2011-01
Rows per page Showing 501–1000 of 1013
Previous 1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Austrian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-austria/city/vienna?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Austria and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,586 studies in total at the last sync on 14 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,013 of those studies with a site in Vienna.

How many clinical trials are recruiting in Vienna?

542 of the 1,013 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:18 UTC sync. A further 49 have not yet opened recruitment, 398 are active but closed to new participants, and 24 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.